FDA OKs Topical Roflumilast for Psoriasis in Kids Aged 6-11 ...Middle East

This marks an expanded indication for the drug, which was first approved for the same indication in July 2022 for individuals aged 12 and older. MDedge News

Hence then, the article about fda oks topical roflumilast for psoriasis in kids aged 6 11 was published today ( Friday 06/10/2023 - 10:33 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA OKs Topical Roflumilast for Psoriasis in Kids Aged 6-11 )

Also on site :

• The Dietitian-Approved Starbucks Matcha Order You Need To Try
• Bulgaria wins Eurovision as Israel finishes second amid protests
• Fresca Turns Its Popular Citrus Soda Into 4 Boozy New Drinks